Shandong Pharmaceutical Glass Co Ltd
SSE:600529
Shandong Pharmaceutical Glass Co Ltd
Other Long-Term Assets
Shandong Pharmaceutical Glass Co Ltd
Other Long-Term Assets Peer Comparison
Competitive Other Long-Term Assets Analysis
Latest Figures & CAGR of Competitors
Company | Other Long-Term Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
S
|
Shandong Pharmaceutical Glass Co Ltd
SSE:600529
|
Other Long-Term Assets
¥37.8m
|
CAGR 3-Years
-52%
|
CAGR 5-Years
-24%
|
CAGR 10-Years
4%
|
Shandong Weigao Group Medical Polymer Co Ltd
HKEX:1066
|
Other Long-Term Assets
¥270.1m
|
CAGR 3-Years
6%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
N/A
|
|
Autobio Diagnostics Co Ltd
SSE:603658
|
Other Long-Term Assets
¥591.4m
|
CAGR 3-Years
28%
|
CAGR 5-Years
45%
|
CAGR 10-Years
N/A
|
|
Winner Medical Co Ltd
SZSE:300888
|
Other Long-Term Assets
¥326.7m
|
CAGR 3-Years
7%
|
CAGR 5-Years
12%
|
CAGR 10-Years
N/A
|
|
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
|
Other Long-Term Assets
¥194.6m
|
CAGR 3-Years
25%
|
CAGR 5-Years
79%
|
CAGR 10-Years
N/A
|
|
Intco Medical Technology Co Ltd
SZSE:300677
|
Other Long-Term Assets
¥65.9m
|
CAGR 3-Years
-57%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
N/A
|
See Also
What is Shandong Pharmaceutical Glass Co Ltd's Other Long-Term Assets?
Other Long-Term Assets
37.8m
CNY
Based on the financial report for Mar 31, 2024, Shandong Pharmaceutical Glass Co Ltd's Other Long-Term Assets amounts to 37.8m CNY.
What is Shandong Pharmaceutical Glass Co Ltd's Other Long-Term Assets growth rate?
Other Long-Term Assets CAGR 10Y
4%
Over the last year, the Other Long-Term Assets growth was -90%. The average annual Other Long-Term Assets growth rates for Shandong Pharmaceutical Glass Co Ltd have been -52% over the past three years , -24% over the past five years , and 4% over the past ten years .